{
    "nctId": "NCT00911911",
    "briefTitle": "Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy",
    "officialTitle": "Analysis of the Proteomic Signature in Breast Cancer Correlated With Tumor Response in Patients Necessitating a Neo-adjuvant Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 66,
    "primaryOutcomeMeasure": "Proteomic analysis by SELDI-TOF on the tumor biopsy and blood samples Histological response according To Chevallier and Sataloff",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged more than 18 years\n* Histologically proven breast carcinoma\n* Neo-adjuvant chemotherapy with anthracyclines and/or taxanes\n* No prior chemotherapy\n* Written informed consent\n\nExclusion Criteria:\n\n* Metastatic disease",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}